A Pilot C11-Choline PET-CT Imaging Study in Patients With Locally Advanced Esophageal Cancer

Wake Forest University Health Sciences1 site in 1 country22 target enrollmentMarch 2010

InterventionsC11-Choline

Overview

Phase: Phase 1
Intervention: C11-Choline
Conditions: Esophageal Cancer
Sponsor: Wake Forest University Health Sciences
Enrollment: 22
Locations: 1
Primary Endpoint: To evaluate our ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer (pre- and post- chemotherapy).
Status: Completed
Last Updated: 7 years ago

The purpose of this study is to evaluate the investigators ability to obtain reliable and meaningful 11C-Choline PET-CT images of esophageal cancer.

Registry

clinicaltrials.gov

Start Date

March 2010

End Date

August 2013

Last Updated

7 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Sponsor

Responsible Party

Sponsor

•Newly diagnosed or recurrent patients with locally advanced esophageal cancer with either squamous or adenocarcinoma histology.
•Ability to tolerate PET imaging
•Prior malignancy is allowed, but the expectation of survival must be that beyond that expected for patients with locally advanced esophageal cancer.

•Pregnant or lactating females are not eligible for this pilot study.
•Patients having received chemotherapy in the 3 months prior to registration for any reason
•Patients with metastatic disease requiring chemoradiation for palliation are not allowed.